Adcock Ingram Holdings | AIP - Sales Revenues


Adcock Ingram Holdings reported ZAR5.05B in Sales Revenues for its fiscal semester ending in June of 2025.



Sales Change Date
Akebia Therapeutics USD 57.34M 10.84M Mar/2025
Alaunos Therapeutics USD 2K 2K Mar/2025
Aspen Pharmacare ZAR 21.4B 557M Jun/2025
Avita Medical AUD 18.42M 14K Jun/2025
Dianthus Therapeutics USD 396K 203K Sep/2025
Ionis Pharmaceuticals USD 157M 295M Sep/2025
IQVIA Holdings USD 4.36B 260M Dec/2025
Life Healthcare ZAR 12.97B 838M Dec/2025
Moderna USD 678M 342M Dec/2025
Netcare ZAR 12.68B 491M Jun/2025
Organon & Co USD 1.51B 90M Dec/2025
Revvity USD 772.06M 73.06M Dec/2025
Tectonic Therapeutic USD 0 0 Dec/2024
Viatris USD 3.76B 190M Sep/2025
Xeris Pharmaceuticals USD 74.38M 2.84M Sep/2025